Harrow, Inc. Common Stock
Symbol: HROW (NASDAQ)
Company Description:
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.
- Today's Open: $48.7
- Today's High: $49.578
- Today's Low: $47.225
- Today's Volume: 157.27K
- Yesterday Close: $48.37
- Yesterday High: $48.79
- Yesterday Low: $47.7
- Yesterday Volume: 517.23K
- Last Min Volume: 412
- Last Min High: $47.805
- Last Min Low: $47.805
- Last Min VWAP: $47.805
- Name: Harrow, Inc. Common Stock
- Website: https://www.harrow.com
- Listed Date: 2007-04-30
- Location: NASHVILLE, TN
- Market Status: Active
- CIK Number: 0001360214
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $1.79B
- Round Lot: 100
- Outstanding Shares: 37.00M
- Asset Type: CS
Filing Date | Filing Type | Format |
---|---|---|
2025-10-01 | 8-K/A | View |
2025-09-29 | 8-K | View |
2025-09-26 | 8-K | View |
2025-09-26 | 8-K | View |
2025-09-19 | 8-K | View |
2025-09-12 | 8-K | View |
2025-09-09 | 4 | View |
2025-09-09 | 3 | View |
2025-09-09 | 8-K | View |
2025-09-08 | 8-K | View |
2025-08-25 | 8-K | View |
2025-08-11 | 10-Q | View |
2025-08-11 | 8-K | View |
2025-07-23 | 4 | View |
2025-07-17 | 8-K | View |
2025-07-01 | 4 | View |
2025-07-01 | 4 | View |
2025-06-24 | 4 | View |
2025-06-24 | 4 | View |
2025-06-24 | 4 | View |